Compare ITW & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITW | PFE |
|---|---|---|
| Founded | 1912 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.0B | 147.6B |
| IPO Year | 1994 | 2013 |
| Metric | ITW | PFE |
|---|---|---|
| Price | $283.95 | $27.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $263.45 | $29.29 |
| AVG Volume (30 Days) | 1.2M | ★ 33.5M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | 2.42% | ★ 6.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.50 | 0.43 |
| Revenue | $14,768,000,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $4.27 | N/A |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | ★ $51.33 | $65.23 |
| Revenue Growth | ★ 3.17 | N/A |
| 52 Week Low | $238.82 | $23.59 |
| 52 Week High | $303.16 | $28.75 |
| Indicator | ITW | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 47.52 | 69.69 |
| Support Level | $242.45 | $24.90 |
| Resistance Level | $285.07 | $28.75 |
| Average True Range (ATR) | 4.51 | 0.54 |
| MACD | -2.09 | 0.16 |
| Stochastic Oscillator | 10.21 | 85.96 |
Founded in 1912, Illinois Tool Works has become a diversified industrial manufacturer through acquisitions and innovations that follow customer needs. ITW operates through seven business segments, with no segment representing more than one-fifth of revenue. ITW's automotive OEM segment sells vehicle components; its food equipment segment sells commercial kitchen appliances; its test and measurement and electronics segment sells inspection and analysis equipment; its welding segment sells welding equipment and consumables; its polymers and fluids segment sells industrial and consumer adhesives, solvents, and coatings; its construction products segment sells building fasteners and tools; and its specialty products segment sells medical, packaging, HVAC, and airport ground equipment.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.